Study of the by-products of benzo[f]indolizines syntheses: A quest towards structural diversity

Targets in Heterocyclic Systems

Volumn 10, Issue , 2006, Pages 232-265

  Rigo, Benoît ^a   Akué Gédu, Rufine ^a  

^a Ecole des Hautes Etudes d'Ingenieur   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84963950818     PISSN: 17249449     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (212)

1. Psychotropic agents: UCB, S.A. Ger. Patent 1972, 2,136,571;
2. Chem. Abs. 1972, 76, 113055y.
3. Lednicer, D.; Mitscher, L. A. The Organic Chemistry of Drug Synthesis; Wiley and Sons: New York, 1977; p. 235.
4. Bocchi, V.; Gardini, G. P.; Pinza, M. Farmaco, Ed. Sci. 1971, 26, 429.
5. Muscarinic acid agonist: Nilsson, B. M.; Ringdahl, B.; Hacksell, U. J. Med. Chem. 1988, 31, 577.
6. Lundkvist, J. R. M.; Wistrand, L.-G.; Hacksell, U. Tetrahedron Lett. 1990, 31, 719.
7. Muscarinic acid antagonist:Nilsson, B. M.; Vargas, H. M.; Ringdahl, B.; Hacksell, U. J. Med. Chem. 1992, 35, 285.
8. Hypertensive agents: Bergmann, R.; Gericke, R. J. Med. Chem. 1990, 33, 492.
9. Mimic of peptide derivatives: Garvey, D. S.; May, P. D.; Nadzan, A. M. J. Org. Chem. 1990, 55, 936.
10. Heffner, R. J.; Joullié, M. M. Tetrahedron Lett. 1989, 30, 7021.
11. Inhibitors of proteolytic catalysis: Corey, E. J.; Li, W.-D. Z. Chem. Pharm. Bull. 1999, 47, 1.
12. Neuraminidase inhibitors: Brouillette, W. J.; Atigadda, V. R.; Luo, M.; Babu, Y. S. U. S. Patent 2003, 6,509,359;
13. Chem. Abs. 2003, 138, 106598j.
14. Absorption promoting agent: Hisamitsu Pharmaceutical Co. Eur. Patent 1987, 241,050
15. Chem. Abs. 1988, 108, 167333w.
16. Immunostimulating agent: Poli Industrial Chimica S.P.A. PCT Int. 1996, 199610036;
17. Chem. Abs. 1996, 125, 115132m.
18. Moret, C.; Briley, M. TIPS, 1998, 9, 278.
19. Goodban, A. E.; Stark, J. B.; Owen, H. S. J. Agr. Food Chem. 1953, 1, 261.
20. Schwartz, J. H.; Greenspan, R. H.; Porter, W. L. Food Technol. 1961, 15, 364.
21. Johnson, F. B.; Hammil, M. M. Can. Inst. Food Technol. 1968, 1, 3.
22. Acree, E.; Lee, C. Y. J. Agr. Food Chem. 1975, 23, 828.
23. Toa Gosei Chemical Industry Co. Ltd. Japan Patent 1971, 71 29,767;
24. Chem Abs. 1972, 77, 57602s.
25. Palekar, A. G.; Tate, S. S.; Sullivan, J. F.; Meister, A. Biochem. Med. 1975, 14, 339.
26. Nordmann, R.; Gauchery, C.; du Ruisseau, J. P.; Thomas, Y.; Nordmann, J. C. Bull. Soc. Chim. Biol. 1982, 36, 1461.
27. For complementary reviews covering the main aspects of pyroglutamic acid chemistry, see: Rigo, B.; Cauliez, P.; Fasseur, D.; Sauvage, F. X. Trends Heterocycl. Chem. 1991, 2, 155.
28. Smith, M. B. Alkaloids 1998, 12, 229.
29. Najera, C.; Yus, M. Tetrahedron: Asymmetry 1999, 10, 2245.
30. Campaigne, E.; Matthews, D. P. J. Heterocycl. Chem. 1975, 12, 391.
31. Ferlux French Patent 1976, 2,273,533;
32. Chem Abs. 1976, 85, 32865x.
33. Kolocouris, N.; Rigo, B. Chim. Chron. New Ser. 1982, 11, 309.
34. Daïch, A.; Decroix, B. J. Heterocycl. Chem. 1996, 33, 873.
35. Rigo, B.; Dolaine, R.; Couturier, D. J. Heterocycl. Chem. 1996, 33, 1063.
36. Rigo, B.; Couturier, D. J. Heterocycl. Chem. 1985, 22, 207.
37. Effenberger, F.; Müller, W.; Keller, R.; Wild, W.; Ziegler, T. J. Org. Chem. 1990, 55, 3064.
38. Rigo, B.; Gautret, P.; Legrand, A.; Hénichart, J.-P.; Couturier, D. Synlett. 1997, 998.
39. Rigo, B.; Gautret, P.; Legrand, A.; Hénichart, J.-P.; Couturier, D. J. Heterocycl. Chem. 1998, 35, 567.
40. Legrand, A.; Rigo, B.; Gautret, P.; Hénichart, J.-P.; Couturier, D. J. Heterocycl. Chem. 1999, 36, 1263.
41. Legrand, A.; Rigo, B.; Hénichart, J.-P.; Norberg, B.; Camus, F.; Durant, F.; Couturier, D. J. Heterocycl. Chem. 2000, 37, 215.
42. Bourry, A.; Rigo, B.; Sanz, G.; Couturier, D. J. Heterocycl. Chem. 2002, 39, 119.
43. Heyl, D.; Harris, S. A.; Folkers, K. J. Am. Chem. Soc. 1948, 70, 3429.
44. Marchalin, S.; Kadlecikova, K.; Bar, N.; Decroix, B. Synth. Commun. 1998, 28, 3619.
45. Szemes, F.; Marchalin, S.; Bar, N.; Decroix, B. J. Heterocycl. Chem. 1998, 35, 1371.
46. Verardo, G.; Geatti, P.; Pol, E.; Giumanini, A. Can. J. Chem. 2002, 80, 779.
47. Bourry, A.; Akué-Gédu, R.; Rigo, B.; Hénichart, J.-P.; Sanz, G.; Couturier, D. J. Heterocycl. Chem. 2003, 40, 989.
48. Rigo, B.; Kolocouris, N. J. Heterocycl. Chem. 1983, 20, 893.
49. Buckley III, T. F.; Rapoport, H. J. Org. Chem. 1983, 48, 4222.
50. Martin, L. L.; Scott, S. J.; Agnew, M. N.; Setescak, L. L. J. Org. Chem. 1986, 51, 3697.
51. Martin, L. L.; Scott, S. J.; Setescak, L. L.; Van Engen, D. J. Heterocycl. Chem. 1987, 24, 1541.
52. Lee, G. S.; Cho, Y. S.; Shim, S. C.; Khim, W. J.; Eibler, E.; Wiegrebe, W. Arch. Pharm. (Weinheim) 1989, 322, 607.
53. Marchalin, S.; Decroix, B.; Morel, J. Acta Chem. Scand. 1993, 47, 287.
54. Rigo, B.; Gautret, P.; Legrand, A.; El Ghammarti, S.; Couturier, D. Synth. Commun. 1994, 24, 2609.
55. Mamouni, A.; Netchitaïlo, P.; Daïch, A; Decroix, B. Phosphorus, Sulfur, and Silicon 1996, 169.
56. Al Akoum Ebrik, S.; Legrand, A.; Rigo, B.; Couturier, D. J. Heterocycl. Chem. 1999, 36, 997.
57. Akué-Gédu, R.; Al Akoum Ebrik, S.; Witczak-Legrand, A.; Fasseur, D.; El Ghammarti, S.; Couturier, D.; Decroix, B.; Othman, M.; Debacker, M.; Rigo, B. Tetrahedron 2002, 58, 9239.
58. Knefeli, F.; Mayer, K. K.; Poettinger, T.; Stöber, G; Wiegrebe, W. Arch. Pharm. (Weinheim) 1983, 316, 773.
59. Kim, H. J.; Yoon, U. C.; Jung, Y.-S.; Park, N. S.; Cederstrom, E. M.; Mariano, P. S. J. Org. Chem. 1998, 63, 860.
60. Some benzo[f]indolizidines are useful for the treatment of neurovegetatives states: American Biogenetic Sciences Inc. PCT Int. 2000, 200004905;
61. Chem. Abs. 2000, 132, 122528t, or are active against fungi:
62. Kubo, A.; Nakai, T.; Koizumi, Y.; Kitahara, Y.; Saito, N.; Mikami, Y.; Yazawa, K.; Uno, J. Heterocycles 1996, 42, 195.
63. For MS studies in these series, see: Mayer, K. K.; Poettingerb T.; Wiegrebe, W. Arch. Pharm. (Weinheim) 1981, 314, 712.
64. Mayer, K. K.; Poettinger, T.; Wiegrebe, W. Arch. Pharm. (Weinheim) 1981, 314, 722.
65. Michael, J. P. Nat. Prod. Rep. 1994, 11, 639.
66. Baker, D.; Cheng, Y.-C.; Zhong, S. WO 2003, 2003/070166.
67. Tylophorine: Khatri, N. A.; Schmitthenner, H. F.; Shringarpure, J; Weinreb, S. M. J. Am. Chem. Soc. 1981, 103, 6387.
68. Nordlander, J. E.; Njoroge, F. G. J. Org. Chem. 1987, 52, 1627.
69. Comins, D. L.; Chen, X.; Morgan, L. A. J. Org. Chem. 1997, 62, 7435, and references cited therein. Tylocrebine: Gellert, E.;
70. Rudzats, R. J. Med. Chem. 1964, 7, 361.
71. Antofine: Tanner, U.; Wiegrebe, W. Arch. Pharm. (Weinheim) 1993, 326, 67.
72. Gopalakrishnan, C.; Shankaranarayan, D.; Kameswaran, L.; Natarajan, S. Indian J. Med. Res. 1979, 69, 513.
73. For reviews, see: Li, Z.; Jin, Z.; Huang, R. Synthesis 2001, 16, 2365.
74. Govindachari, T. R.; Viswanathan, N. Heterocycles 1978, 11, 587.
75. Bourry, A.; Akué-Gédu, R.; Hénichart, J.-P.; Sanz, G.; Rigo, B. Tetrahedron Lett. 2004, 45, 2097.
76. Knochel, P.; Chou, T. S.; Jubert, C.; Rajagopal, D. J. Org. Chem. 1993, 58, 588.
77. Kolocouris, A.; Kolocouris, N.; Foscolos, G. B.; Fytas, G.; Hempel, A.; Camerman, N.; Camerman, A.; Hamodrakas, S. J. J. Cryst. Spectr. Res. 1993, 23, 663.
78. Johnson and Johnson Pharmaceutical Research and Development, Campus de Maigremont, 27106 Val de Reuil, France.
79. Rigo, B.; Fasseur, D.; Cherepy, N.; Couturier, D. Tetrahedron Lett. 2004, 30, 7057.
80. Mahsimov, V. I. Tetrahedron 1965, 21, 687.
81. Rapoport, H. Lect. Heterocycl. Chem. 1978, IV, S-47.
82. Von Braun, J.; Blessing, G.; Cahn, R. S. Chem. Ber. 1924, 57, 908.
83. Von Braun, J.; Bayer, O. Chem. Ber. 1927, 60, 1257.
84. Zamorani, A.; Roda, G.; Riva, A. Ann. Chim. (Rome) 1972, 62, 177.
85. Ochiai, M.; Inenaga, M.; Nagao, Y.; Moriarty, R. M.; Vaid, R. K.; Duncan, M. P. Tetrahedron Lett. 1988, 29, 6917.
86. Iwasaki, T.; Horikawa, H.; Matsumoto, K.; Miyoshi, M. J. Org. Chem. 1979, 44, 1152.
87. Rigo, B.; Lelieur, J. P.; Kolokouris, N. Synth. Commun. 1986, 16, 1587.
88. Boto, A.; Hernández, R.; Suárez, E. J. Org. Chem. 2000, 65, 4930.
89. Iglesias-Arteaga, M.; Juaristi, E.; González, F. J. Tetrahedron 2004, 60, 3605.
90. Maryanoff, B. E.; Zhang, H.-C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 1431.
91. Royer, J.; Bonin, M.; Micouin, L. Chem. Rev. 2004, 104, 2311.
92. See also: Winn, M.; Zaugg, H. E. J. Org. Chem. 1968, 33, 3779.
93. Boer-Terpstra, T. J.; Dijhink, J.; Shoemaker, H. E.; Speckamp, W. N. Tetrahedron Lett. 1977, 11, 939.
94. Maryanoff, B. E.; McComsey, D. F.; Duhl-Emswiler, B. A. J. Org. Chem. 1983, 48, 5062.
95. Speckamp, W. N.; Hiemstra, H. Tetrahedron 1985, 41, 4367.
96. Hiemstra, H.; Speckamp, W. N. The Alkaloids; Academic Press: New York, 1988; Vol. 32, p. 271.
97. Maryanoff, B. E.; Rebarchak, M. C. Synthesis 1992, 1245.
98. Speckamp, W. N.; Moolenaar, M. J. Tetrahedron 2000, 56, 3817.
99. Lee, J. Y.; Baek, N. J.; Lee, S. J.; Park, H.; Lee, Y. S. Heterocycles 2001, 55, 1519.
100. For a review, see: Shono, T. Tetrahedron 1984, 40, 811.
101. Onda, M.; Yuasa, K.; Okada, J. Chem. Pharm. Bull. 1974, 22, 2365.
102. McDonald, S. J. F.; Inglis, G. G. A.; Bentley, D.; Dowle, M. D. Tetrahedron Lett. 2002, 43, 5057.
103. Baker, J. T.; Sifniades, S. J. Org. Chem. 1979, 44, 2798.
104. Pernot, A.; Willemart, A. Bull. Soc. Chim. France 1953, 324.
105. Sato, T.; Chono, N.; Ishibashi, H.; Ikeda, M. J. Chem. Soc., Perkin Trans. 1 1995, 1115.
106. Machouhi, F.; Namy, J.-L. Tetrahedron 1998, 54, 11111.
107. Barker, C. V.; Korn, S. R.; Monteith, M.; Page, M. I. Chem. Comm. 1999, 721.
108. Tsuji, M.; Higashiyama, K.; Yamauchi, T.; Kubo, H.; Ohmiya, S. Heterocycles 2001, 54, 1027.
109. Iwai, T.; Ito, T.; Mizuno, T.; Ishino, Y. Tetrahedron Lett. 2004, 45, 1083.
110. Newhouse, B.; Allen, S.; Fauber, B.; Anderson, A.; Eary, C. T.; Hansen, J. D.; Schiro, J.; Gaudino, J. J.; Laird, E.; Chantry, D.; Eberhardt, C.; Burgess. L. E. Bioorg. Med. Chem. Lett. 2004, 14, 5537.
111. Kleber, C.; Andrade, Z.; Matos, R. A. F. Synlett 2003, 1189.
112. Nagasaka, T.; Abe, M.; Ozawa, N.; Kosugi, Y.; Hamaguchi, F. Heterocycles 1983, 20, 985.
113. See also: Katritzky, A. R.; Manju, K.; Singh, S. K.; Meher, N. K. Tetrahedron 2005, 61, 2555.
114. Wei, Z. Y.; Knaus, E. E. Org. Prep. Proc. Int. 1993, 25, 255.
115. Eaton, P. E.; Carlson, G. R.; Lee, J. T. J. Org. Chem. 1973, 38, 4071.
116. Seong, M. R.; Kim, J. N. Bull. Kor. Chem. Soc. 1999, 20, 1253.
117. For a review on the decarbonylative carbon-carbon bond formation, see: Hino, T.; Kameda, A.; Yonezawa, N. Rec. Res. Dev. Org. Chem. 2000, 3, 75.
118. Baraldi, P. G.; Cacciari, B.; Guiotto, A.; Romagnoli, R.; Spalluto, G. Rec. Res. Dev. Org. Chem. 1998, 2, 567.
119. Reddy, B. S. P.; Sondhy, S. M.; Lown, J. W. Pharm. Ther. 1999, 84, 1.
120. Kamal, A.; Rao, M. V.; Laxman, N.; Ramesh, G.; Reddy, G. S. K. Curr. Med. Chem.: Anti Cancer Agents 2002, 2, 215.
121. El Ghammarti, S.; Rigo, B.; Mejdi, H.; Hénichart, J.-P.; Couturier, D. J. Heterocycl. Chem. 1998, 35, 555.
122. Rigo, B.; El Ghammarti, S.; Couturier, D. Tetrahedron Lett. 1996, 37, 485.
123. El Ghammarti, S.; Rigo, B.; Mejdi, H.; Hénichart, J.-P.; Couturier, D. J. Heterocycl. Chem. 2000, 37, 143.
124. See however: Kraus, G. A.; Yue, S. J. Org. Chem. 2000, 65, 655.
125. Magnus, P.; Hulme, C.; Weber, W. J. Am. Chem. Soc. 1994, 116, 4501.
126. Frank, K.; Aubé, J. Tetrahedron Lett. 1998, 39, 7239.
127. Frank, K. E.; Aubé, J. J. Org. Chem. 2000, 65, 655.
128. Roth, E.; Altman, J.; Kapan, M.; Ben-Ishai, D. Tetrahedron 1995, 30, 801.
129. Savel, H. Proc. Am. Assoc. Cancer Res. 1964, 5, 56.
130. Stahelin, H. Eur. J. Cancer 1970, 6, 303.
131. Jardine, I. Anticancer Agents Based on Natural Products Models; Academic Press, Inc.: New York, NY, 1980; p. 319.
132. Long, B. G.; Musial, S. F.; Brattain, M. G. Biochemistry 1984, 23, 1183.
133. Liu, S. Y.; Hwang, B. D.; Haruna, M.; Imakura, Y.; Lee, K. H.; Cheng, Y. C. Mol. Pharmacol. 1989, 36, 78.
134. Liénard, P.; Royer, J.; Quirion, J. C.; Huson, H.-P. Tetrahedron Lett. 1991, 32, 2489.
135. Leteurtre, F.; Madalengoitia, J.; Orr, A.; Cuzi, T. J.; Lehnert, E.; McDonald, T.; Pommier, Y. Cancer Res. 1992, 52, 4478.
136. Liénard, P.; Quirion, J. C.; Huson, H.-P. Tetrahedron 1993, 49, 3995.
137. Leteurtre, F.; Sackett, D. L.; Madalengoitia, J.; Kohlhagen, G.; McDonald, T.; Hamel, E.; Paull, K. D.; Pommier, Y. Biochem. Pharmacol. 1995, 49, 1283.
138. Rigo, B.; Lespagnol, C.; Pauly, M. J. Heterocycl. Chem. 1988, 25, 49.
139. Bourry, A.; Pitard, F.; Rigo, B.; Sanz, G.; Camus, F.; Norberg, B.; Durant, F.; Couturier, D. J. Heterocycl. Chem. 2002, 39, 109.
140. Gautret, P.; El Ghammarti, S.; Legrand, A.; Couturier, D.; Rigo, B. Synth. Commun. 1996, 26, 707.
141. Camus, F.; Norberg, B.; Legrand, A.; Rigo, B.; Durant, F.; Wouters, J. Acta Cryst. 2000, C56, 193.
142. Rigo, B.; Barbry, D.; Couturier, D. Synth. Commun. 1991, 21, 741.
143. Some benzo[c]-1,5-naphthyridines obtained theses Semmler-Wolffrearrangements are useful for treatment of brain disorders: Hoechst-Roussel Pharmaceutical Inc. U. S. Patent 1988, 4,742,061;
144. Chem. Abs. 1989, 110, 114817s.
145. Greene, T. W.; Wuts,. P. G. M. Protective Groups in Organic Synthesis; John Wiley and Sons: New York, 1999; p. 639.
146. Rigo, B.; Tullier, E.; Barbry, D.; Couturier, D.; Warin, V.; Lamiot, J.; Baert, F. J. Heterocycl. Chem. 1990, 27, 1383.
147. Akué-Gédu, R.; Bourry, A.; Camus, F.; Norberg, B.; Durant, F.; Couturier, D.; DeBacker, M.; Rigo, B. Heterocycles 2004, 63, 1855.
148. The distance between two corresponding centroids is 3.89 Å: Camus, F.; Norberg, B.; Bourry, A.; Akué-Gédu, R.; Rigo, B.; Durant, F. Acta Cryst. 2003, E59, 1002.
149. Aromatization of heterocyclic ketones induced by hydride transfer in acidic media: Lee-Ruff, E.; Chung, Y.-S. J. Heterocycl. Chem. 1986, 23, 1551.
150. Lee-Ruff, E.; Chung, Y.-S. J. Heterocycl. Chem. 1990, 27, 899.
151. Bimolecular hydride transfers leading to stabilized carbocations: Germain, J. E. Catalytic Conversion of Hydrocarbons; Academic Press: New York, 1969; pp. 179-185.
152. Nyberg, K. Synthesis 1976, 545. SciFinder search.
153. Dimerization of enamides (such as compound 56, Scheme 21) in acidic medium leads to mono unsaturated dimers: Heredia, M. L.; De la Cuesta, E.; Avendaño, C. Tetrahedron 2002, 58, 6163.
154. Fajardo, V.; Cárcamo, C.; Moreno, B. Heterocycles 1996, 43, 949.
155. Elango, V.; Shamma, M. J. Org. Chem. 1983, 48, 4879.
156. Norman, R. O. C. Principles of Organic Syntheses; Methuen and Co.: London, England, 1968; p. 487.
157. Huffman, J. W.; Wallace, R. H. J. Am. Chem. Soc. 1989, 111, 8691.
158. Hirao, T. Synlett 1999, 2, 175.
159. McMurry, J. E. Chem. Rev. 1989, 89, 1513.
160. Burgess, V. A.; Easton, C. J. Tetrahedron Lett. 1987, 28, 2747.
161. Easton, C. J.; Peters, S. C.; Love, S. G. Heterocycles 1988, 27, 2305.
162. Parsons, A. F. C. R. Acad. Sci. Paris, C. 2001, 391.
163. Baba, D.; Fuchigami, T. Tetrahedron Lett. 2002, 43, 4805.
164. Rathore, R.; Kochi, J. K. Acta Chem. Scand. 1998, 52, 114.
165. Pesaro, M.; Felner-Laoga, I.; Eschenmoser, A. Chimia 1965, 19, 566.
166. Obata, N.; Nimura, K. Chem. Commun. 1977, 238.
167. Taniguchi, H.; Kirino, Y. J. Am. Chem. Soc. 1977, 99, 3625.
168. Trudell, M. L.; Fukada, N.; Cook, J. M. J. Org. Chem. 1987, 52, 4293.
169. Hagen, T. J.; Narayanan, K.; Names, J.; Cook, J. M. J. Org. Chem. 1989, 54, 2170.
170. Aromatization of aminoketone can also occur in basic media: Busacca, C. A.; Eriksson, M. C.; Dong, Y.; Prokopowicz, A. S.; Salvagno, A. M.; Tschantz, M. A. J. Org. Chem. 1999, 64, 4564.
171. Wynne, J. H.; Stalick, W. M. J. Org. Chem. 2003, 68, 4845.
172. Lenz, G. R.; Woo, C.-M. J. Org. Chem. 1982, 47, 3049.
173. Meth-Cohn, O.; Westwood, K. T. J. Chem. Soc., Perkin Trans. 1 1984, 1173.
174. Katritzky, A. R.; Rachwal, S.; Rachwal, B. J. Org. Chem. 1994, 59, 5206.
175. Pigeon, P.; Decroix, B. Bull. Soc. Chim. France 1997, 134, 153.
176. Morzycki, J. W.; Lotowski, Z.; Stepniowska, M.; Gryszkiewicz, A.; Wilczewska, Z. Tetrahedron 1997, 53, 16161.
177. Bourry, A.; Couturier, D.; Sanz, G.; Van Hijfte, L.; Hénichart, J.-P.; Rigo, B. Tetrahedron 2006, 62, 4400.
178. Sánchez, J. D.; Ramos, M. T.; Avendaño, C. J. Org. Chem. 2001, 66, 5731.
179. This oxidation can be catalyzed by metals such as ruthenium: Murahashi, S.-I.; Saito, T.; Naota, T.; Kumobayashi, H.; Akutagawa, S. Tetrahedron Lett. 1991, 32, 5991.
180. Haeusler, J.; Jahn, R.; Schmidt, U. Chem. Ber. 1978, 111, 361.
181. Yates, P.; McLachland, F. M. J. Indian. Chem. Soc. 1978, 55, 1116.
182. Kessar, V. S.; Singh, T.; Vohra, R. Indian J. Chem. 1991, 30B, 299.
183. Mori, M.; Kimura, M.; Uozumi, Y.; Ban, Y. Tetrahedron Lett. 1985, 26, 5947, and references cited therein.
184. Dörwald, F. Z. Side reactions in Organic Synthesis; Wiley-VCH: Weinheim, 2005; p. 50.
185. Barton, D. H. R.; Jones, D. L. J. Chem. Soc. 1965, 3563.
186. Moniot, J. L.; Shamma, M. J. Org. Chem. 1979, 44, 4337.
187. For other leading references on the chemistry of ?-keto carbinolamides in the Berberin series, see ref. 67 and: Moniot, J. L.; Shamma, M. J. Am. Chem. Soc. 1976, 98, 6714.
188. Dorn, C. R.; Koszyk, F. J.; Lenz, G. R. J. Org. Chem. 1984, 49, 2642.
189. Fang. F. G.; Danishefsky, S. J. Tetrahedron Lett. 1981, 30, 2747.
190. Yoda, H.; Inoue, K.; Ujihara, Y.; Mase, N.; Takabe, K. Tetrahedron Lett. 2003, 44, 9057.
191. Imai, J.; Kondo, Y. Heterocycles 1977, 6, 959.
192. Koseki, Y.; Kusano, S.; Sakata, H.; Nagasaka, T. Tetrahedron Lett. 1999, 40, 2169.
193. Moniot, J. L.; Hindenlang, D. M.; Shamma, M. J. Org. Chem. 1979, 44, 4343.
194. Alonso, R.; Castedo, L.; Dominguez, D. Tetrahedron Lett. 1985, 26, 2925.
195. However see also: Moniot, J. L.; Hindenlang, D. M.; Shamma, M. J. Org. Chem. 1979, 44, 4347, for a previously attributed structure.
196. Bhattacharya, G.; Su, T.-L.; Chia, C.-M.; Chen, K.-T. J. Org. Chem. 2001, 66, 426.
197. Renz, M.; Meunier, B. Eur. J. Org. Chem. 1997, 737.
198. Compostella, F.; Colombo, D.; Modica, E.; Scala, A.; Toma, L.; Bovio, B.; Ronchetti, F. Steroids 2002, 67, 111.
199. Jones, P. B.; Porter, N. A. J. Am. Chem. Soc. 1999, 121, 2753.
200. Jones, P. B.; Pollastri, M. P.; Porter, N. A. J. Org. Chem. 1996, 61, 9455.
201. Kondo, Y.; Imai, J.; Inoue, H. J. Chem. Soc., Perkin Trans. 1 1980, 911.
202. Kondo, Y.; Imai, J.; Nozoe, S. J. Chem. Soc., Perkin Trans. 1 1980, 919.
203. Potmesil, M.; Kohn, K. W. DNA Topoisomerases in Cancer; Oxford University Press: New York, 1991.
204. Pratt, W. B.; Ruddon, R. W.; Ensminger, W. D.; Maybaum, J. The anticancer Drugs; Oxford University Press: New York, 1994.
205. Wang, H.-K.; Morris-Natschke, S. L.; Lee, K.-H. Med. Res. Rev. 1997, 17, 367.
206. Schoeffler, A. J.; Berger, J. M. Biochem. Soc. Trans. 2005, 33, 1465.
207. Akué-Gédu, R. Conception Rationelle et Synthèse d'Inhibiteurs Potentiels de la Topoisomérase II. Synthèse complète de la Camptothécine; Lille, France, 2004, unpublished results.
208. Biswas, K. M.; Jackson, A. H. Tetrahedron 1968, 24, 1145.
209. Plieninger, H.; Wagner, C.; Immel, H. Liebigs Ann. Chem. 1971, 743, 95.
210. Vangveravong, S.; Kanthasamy, A.; Lucaltes, V. L.; Nelson, D. L.; Nichols, D. E. J. Med. Chem. 1998, 41, 4995.
211. Dean, F. M.; Goodchild, J.; Houghton, L. E.; Martin, J. A.; Morton, R. B.; Parton, B.; Price, A. W.; Somvichien, N. Tetrahedron Lett. 1966, 4153.
212. Brook, M. A.; Chan, T. H. Synthesis 1983, 201.